This diagnostic image set displays quantitative T1ρ (T1-rho) MR imaging maps, a specialized neuroimaging modality used to probe metabolic and pH-related changes in the brain. The visualization consists of two rows of brain slices in axial, sagittal, and coronal planes, contrasting 'T1ρ Relationship with Mania' (top) and 'T1ρ Relationship with Depression' (bottom) in the context of Bipolar Disorder. Functional data is overlaid on structural templates, with a color-coded t-statistic scale ranging from -5.0 (blue) to +5.0 (yellow/orange). In both mania and depression states, there is a consistent decrease in T1ρ signal (blue regions) within the basal ganglia and thalamus, indicating a negative t-statistic between -2.5 and -5.0. During the manic phase, additional signal decreases are visible in the hippocampus and cerebellum, while increased signal (yellow) is noted in the inferior frontal and temporal cortex. This comparison illustrates how T1ρ imaging can identify regional metabolic variations associated with specific psychiatric mood states.

Summary : This Venn diagram compares the overlapping and distinct symptoms of three major psychiatric disorders—recurrent major depression, schizophrenia and psychotic disorders, and bipolar disorders—highlighting their shared impact on decreased level of functioning. venn diagram: # Disorders Compared : • Recurrent major depression • Schizophrenia and psychotic disorders • Bipolar disorders # Symptom Lists : ## Recurrent major depression : • Depressive mood • Cognitive symptoms, attention and memory deficits • Delusions, hallucinations • Psychomotor restlessness or impairment • Suicidality ## Schizophrenia and psychotic disorders : • Depressive mood, loss of pleasure • Cognitive symptoms from multiple domains • Delusions, hallucinations • Psychomotor restlessness • Negative symptoms • Suicidality ## Bipolar disorders : • Elevated or depressive mood • Cognitive symptoms, attention and memory deficits • Delusions, hallucinations • Psychomotor restlessness or impairment • Suicidality # Central Overlap (Shared Features) : • Decreased level of functioning (illustrated by a person sitting with head down) • Delusions, hallucinations • Psychomotor restlessness or impairment • Suicidality • Cognitive symptoms # Design Encodings : • Three overlapping circles, each shaded differently and labeled with the disorder name. • Central overlap contains an illustration of a person and the phrase “Decreased level of functioning.” • Each disorder’s symptoms are listed in bullet points within its respective circle. • ESC logo in the bottom right corner. # Analysis : • All three disorders share several core symptoms: cognitive impairment, delusions/hallucinations, psychomotor changes, and suicidality, which collectively contribute to decreased functioning. • Schizophrenia and psychotic disorders uniquely list “negative symptoms” and “loss of pleasure.” • Bipolar disorder uniquely includes “elevated mood.” • The diagram visually emphasizes the substantial overlap in symptoms and functional impairment among these psychiatric conditions.

This composite diagnostic image presents statistical parametric maps and bar graphs demonstrating differences in dynamic degree centrality (dDC) variability in the brain among four clinical groups: bipolar depression (BD), bipolar mania (BM), bipolar euthymia (BE), and healthy controls (HCs). The content is organized into two panels (A and B). Panel A displays sagittal, coronal, and axial views of the brain with heat-map clusters (yellow/red) in the left inferior parietal lobule and middle occipital gyrus (IPL/MOG). An adjacent bar graph shows significant decreases in dDC variability in the BD group compared to BM, BE, and HCs in this region. Panel B displays similar brain views highlighting the right precuneus and posterior cingulate cortex (PCUN/PCC). The corresponding bar graph reveals that both BD and BM groups exhibit decreased dDC variability compared to the BE group. Color bars indicate F-values ranging from 0 to 10. The image illustrates neuroimaging findings in bipolar disorder, highlighting abnormal intrinsic brain connectivity variability as a potential biomarker for different mood states.

This pathophysiology diagram illustrates the potential mechanisms of action for Acetylsalicylic Acid (ASA) in the treatment and prevention of mood disorders. The central element is the chemical structure of ASA, which branches out to four key neurological and immunological domains. 1) Neuroinflammation: ASA is associated with decreased levels of prostaglandin E2, proinflammatory cytokines, and oxidative stress biomarkers (COX-1/COX-2), while potentially influencing microglial activation and oligodendroglial differentiation. 2) COX System: The diagram depicts the direct inhibition of cyclooxygenase enzymes, leading to a downstream reduction in inflammatory mediators. 3) Neurotransmission: The visual indicates a role in rebalancing neurotransmitters via the arachidonic acid pathway (COX-2), interacting with mood stabilizers. 4) PPARα Pathways: ASA is shown to enhance neuroplasticity, brain-derived neurotrophic factor (BDNF) levels, and plaque clearance. Directional arrows signify the increase or decrease of specific biological processes and molecular markers, summarizing how ASA acts as a multi-target modulator within the central nervous system to alleviate symptoms of depression and bipolar disorder.